Cargando…
JNK pathway‐associated phosphatase in acute ischemic stroke patients: Its correlation with T helper cells, clinical properties, and recurrence risk
OBJECTIVE: JKAP modifies T‐cell immune response and inflammation, also involves in cardia‐cerebrovascular disease etiology. This study intended to explore JKAP's relation with T‐helper 1 (Th1), T‐helper 17 (Th17) cell levels, clinical properties, and recurrence‐free survival (RFS) in acute isch...
Autores principales: | Zhao, Ping, Huo, Huiyong, Li, Juntao, Zhang, Wenchao, Liu, Chao, Jin, Bei, Wang, Huijuan, Wang, Chaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396169/ https://www.ncbi.nlm.nih.gov/pubmed/35808912 http://dx.doi.org/10.1002/jcla.24535 |
Ejemplares similares
-
The longitudinal changes of serum JKAP and IL‐17A, and their linkage with anxiety, depression, and cognitive impairment in acute ischemic stroke patients
por: Wang, Chaohui, et al.
Publicado: (2022) -
JNK pathway‐associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T‐helper 17 cells in inflammatory bowel disease children
por: Wang, Caixia, et al.
Publicado: (2022) -
Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway
por: Ha, Jain, et al.
Publicado: (2019) -
Triglyceride-glucose index and stroke recurrence in elderly patients with ischemic stroke
por: Wang, Fang, et al.
Publicado: (2022) -
tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
por: Kim, Jong S.
Publicado: (2019)